⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Prollenium Medical Technologies Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Prollenium Medical Technologies Inc.
↗Aurora, Ontario, Canada
Prollenium Medical Technologies is a Canadian-based, privately held medical aesthetics company founded in 2002. It specializes in the research, development, and in-house manufacturing of hyaluronic acid (HA) dermal fillers, most notably the Revanesse line, and is recognized as the only manufacturer of HA dermal fillers in North America.
The company operates with a focus on vertical integration, managing R&D, manufacturing, and distribution from its headquarters in Aurora, Ontario. Recently, Prollenium has announced a strategic shift toward advanced skin regeneration technologies, including PDRN, exosome-based therapies, and collagen-stimulating biostimulants, aiming to expand beyond traditional dermal fillers into broader skin health and longevity solutions.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$25M-$50M
Founded:2002
Ownership:private
Status:operating
FUNDING
Total Raised:$0
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Revanesse line)
Modalities:Hyaluronic Acid (HA) fillers, Biostimulants, Exosome-based therapies
Active Trials:0
Trial Phases:-
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various global distribution partnerships to support presence in 80+ countries.
COMPETITION
Position:Niche Player
Competitors:Galderma, Allergan Aesthetics (AbbVie), Merz Aesthetics
LEADERSHIP
Key Executives:
Walter Geiger - Acting CEO
Ario Khoshbin - Founder
Scientific Founders:Ario Khoshbin
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Prollenium Medical Technologies Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.